Crohn's Disease study: Iron
Official title Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease
ClinicalTrials.gov ID: NCT07925450
What this study is testing
What is Iron (ferrous sulfate)?
Iron (ferrous sulfate) is an investigational medicine, being studied as a potential treatment for crohn's disease.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Children and young adults with Crohn's disease may develop iron deficiency anemia, a condition in which low iron levels reduce the number of healthy red blood cells.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 21
You may be able to join if
- Male or female
- 3 to 21 years of age
- Biopsy confirmed Crohns disease involving gastric, duodenal, and/or jejunal mucosa
- Quiescent Crohns disease, assessed by histopathology, CRP, ESR, and PCDAI scores
- Iron deficiency anemia, defined as hemoglobin or transferrin saturation below age-defined norms and/or MCV \<80.
You likely can't join if
- antibiotic use with 6 weeks of endoscopic evaluation
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.